16-84178966-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001243156.2(TAF1C):c.2507G>A(p.Arg836Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000311 in 1,609,798 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001243156.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TAF1C | NM_001243156.2 | c.2507G>A | p.Arg836Gln | missense_variant | 15/15 | ENST00000566732.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TAF1C | ENST00000566732.6 | c.2507G>A | p.Arg836Gln | missense_variant | 15/15 | 2 | NM_001243156.2 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152170Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000690 AC: 17AN: 246272Hom.: 0 AF XY: 0.0000450 AC XY: 6AN XY: 133420
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1457510Hom.: 0 Cov.: 50 AF XY: 0.0000179 AC XY: 13AN XY: 725070
GnomAD4 genome AF: 0.000112 AC: 17AN: 152288Hom.: 0 Cov.: 33 AF XY: 0.0000940 AC XY: 7AN XY: 74458
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 02, 2024 | The c.2585G>A (p.R862Q) alteration is located in exon 14 (coding exon 13) of the TAF1C gene. This alteration results from a G to A substitution at nucleotide position 2585, causing the arginine (R) at amino acid position 862 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at